{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:35:07Z","timestamp":1794652507371,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","award":["Australian Government Research Training Program"],"award-info":[{"award-number":["Australian Government Research Training Program"]}],"id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculty of Science, University of Technology Sydney","id":[{"id":"https:\/\/ror.org\/03f0f6041","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Preeclampsia is still the leading cause of morbidity and mortality in pregnancy without a cure. There are two phenotypes of preeclampsia, early-onset (EOPE) and late-onset (LOPE) with poorly defined pathogenic differences. This study aimed to facilitate better understanding of the mechanisms of pathophysiology of EOPE and LOPE, and identify specific biomarkers or therapeutic targets. In this study, we conducted an untargeted, label-free quantitative proteomic analyses of plasma samples from pregnant women with EOPE (n\u2009=\u200917) and LOPE (n\u2009=\u200911), and age, BMI-matched normotensive controls (n\u2009=\u200918). Targeted proteomics approach was also employed to validate a subset of proteins (n\u2009=\u200917). In total, there were 26 and 20 differentially abundant proteins between EOPE or LOPE, and normotensive controls, respectively. A series of angiogenic and inflammatory proteins, including insulin-like growth factor-binding protein 4 (IGFBP4; EOPE: FDR\u2009=\u20090.0030 and LOPE: FDR\u2009=\u20090.00396) and inter-alpha-trypsin inhibitor heavy chain H2-4\u00a0(ITIH2-4), were significantly altered in abundance in both phenotypes. Through validation we confirmed that ITIH2 was perturbed only in LOPE (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005) whereas ITIH3 and ITIH4 were perturbed in both phenotypes (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Overall, lipid metabolism\/transport proteins associated with atherosclerosis were highly abundant in LOPE, however, ECM proteins had a more pronounced role in EOPE. The complement cascade and binding and uptake of ligands by scavenger receptors, pathways, were associated with both EOPE and LOPE.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-20658-x","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:02:51Z","timestamp":1667991771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia"],"prefix":"10.1038","volume":"12","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Aneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Karadzov Orlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Mikovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Cakic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristina","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E. L.","family":"Town","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"20658_CR1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. Report of the american college of obstetricians and gynecologists\u2019 Task force on hypertension in pregnancy. Obstet. Gynecol. 122, 1122\u20131131. https:\/\/doi.org\/10.1097\/01.AOG.0000437382.03963.88 (2013).","journal-title":"Obstet. Gynecol."},{"key":"20658_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","volume":"4","author":"AL Tranquilli","year":"2014","unstructured":"Tranquilli, A. L. et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 4, 97\u2013104. https:\/\/doi.org\/10.1016\/j.preghy.2014.02.001 (2014).","journal-title":"Pregnancy Hypertens."},{"key":"20658_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","volume":"4","author":"LA Magee","year":"2014","unstructured":"Magee, L. A. et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 4, 105\u2013145. https:\/\/doi.org\/10.1016\/j.preghy.2014.01.003 (2014).","journal-title":"Pregnancy Hypertens."},{"key":"20658_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1081\/prg-100100138","volume":"19","author":"DJ Murphy","year":"2000","unstructured":"Murphy, D. J. & Stirrat, G. M. Mortality and morbidity associated with early-onset preeclampsia. Hypertens. Pregnancy 19, 221\u2013231. https:\/\/doi.org\/10.1081\/prg-100100138 (2000).","journal-title":"Hypertens. Pregnancy"},{"key":"20658_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","volume":"195","author":"RB Ness","year":"2006","unstructured":"Ness, R. B. & Sibai, B. M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am. J. Obstet. Gynecol. 195, 40\u201349. https:\/\/doi.org\/10.1016\/j.ajog.2005.07.049 (2006).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20658_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai, B. & Dekker, G. Kupferminc M. Pre-eclampsia. Lancet 365, 785\u2013799. https:\/\/doi.org\/10.1016\/S0140-6736(05)17987-2 (2005).","journal-title":"Pre-eclampsia. Lancet"},{"key":"20658_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12014-021-09313-1","volume":"18","author":"R Navajas","year":"2021","unstructured":"Navajas, R., Corrales, F. & Paradela, A. Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004\u20132020 period: A systematic review. Clin. Proteomics 18, 6. https:\/\/doi.org\/10.1186\/s12014-021-09313-1 (2021).","journal-title":"Clin. Proteomics"},{"key":"20658_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2407-8-25","volume":"8","author":"A Hamm","year":"2008","unstructured":"Hamm, A. et al. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis. BMC Cancer 8, 25. https:\/\/doi.org\/10.1186\/1471-2407-8-25 (2008).","journal-title":"BMC Cancer"},{"key":"20658_CR9","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1074\/jbc.M111.267732","volume":"287","author":"LW Contois","year":"2012","unstructured":"Contois, L. W. et al. Insulin-like growth factor binding protein-4 differentially inhibits growth factor-induced angiogenesis. J. Biol. Chem. 287, 1779\u20131789. https:\/\/doi.org\/10.1074\/jbc.M111.267732 (2012).","journal-title":"J. Biol. Chem."},{"key":"20658_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1593\/neo.13212","volume":"15","author":"MJ Moreno","year":"2013","unstructured":"Moreno, M. J. et al. IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity. Neoplasia 15, 554\u2013567. https:\/\/doi.org\/10.1593\/neo.13212 (2013).","journal-title":"Neoplasia"},{"key":"20658_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/glia.20345","volume":"53","author":"MJ Moreno","year":"2006","unstructured":"Moreno, M. J., Ball, M., Andrade, M. F., McDermid, A. & Stanimirovic, D. B. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 53, 845\u2013857. https:\/\/doi.org\/10.1002\/glia.20345 (2006).","journal-title":"Glia"},{"key":"20658_CR12","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s11033-020-05339-0","volume":"47","author":"MG Dallinga","year":"2020","unstructured":"Dallinga, M. G. et al. IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis. Mol. Biol. Rep. 47, 2561\u20132572. https:\/\/doi.org\/10.1007\/s11033-020-05339-0 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"20658_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10456-013-9363-8","volume":"16","author":"J Cedervall","year":"2013","unstructured":"Cedervall, J. et al. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment. Angiogenesis 16, 889\u2013902. https:\/\/doi.org\/10.1007\/s10456-013-9363-8 (2013).","journal-title":"Angiogenesis"},{"key":"20658_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI9061","volume":"107","author":"R Simantov","year":"2001","unstructured":"Simantov, R. et al. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J. Clin. Invest. 107, 45\u201352. https:\/\/doi.org\/10.1172\/JCI9061 (2001).","journal-title":"J. Clin. Invest."},{"key":"20658_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.can-03-1941","volume":"64","author":"AK Olsson","year":"2004","unstructured":"Olsson, A. K. et al. A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res. 64, 599\u2013605. https:\/\/doi.org\/10.1158\/0008-5472.can-03-1941 (2004).","journal-title":"Cancer Res."},{"key":"20658_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/ajh.2010.264","volume":"24","author":"M Bolin","year":"2011","unstructured":"Bolin, M., Akerud, P., Hansson, A. & Akerud, H. Histidine-rich glycoprotein as an early biomarker of preeclampsia. Am. J. Hypertens. 24, 496\u2013501. https:\/\/doi.org\/10.1038\/ajh.2010.264 (2011).","journal-title":"Am. J. Hypertens."},{"key":"20658_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41440-018-0013-9","volume":"41","author":"A Aksornphusitaphong","year":"2018","unstructured":"Aksornphusitaphong, A. & Phupong, V. Combination of serum histidine-rich glycoprotein and uterine artery Doppler to predict preeclampsia. Hypertens. Res. 41, 275\u2013281. https:\/\/doi.org\/10.1038\/s41440-018-0013-9 (2018).","journal-title":"Hypertens. Res."},{"key":"20658_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/00016340903295618","volume":"89","author":"K Karehed","year":"2010","unstructured":"Karehed, K. et al. Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia. Acta Obstet. Gynecol. Scand. 89, 131\u2013139. https:\/\/doi.org\/10.3109\/00016340903295618 (2010).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"20658_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/0002-9378(92)91663-u","volume":"166","author":"DB Brubaker","year":"1992","unstructured":"Brubaker, D. B., Ross, M. G. & Marinoff, D. The function of elevated plasma fibronectin in preeclampsia. Am. J. Obstet. Gynecol. 166, 526\u2013531. https:\/\/doi.org\/10.1016\/0002-9378(92)91663-u (1992).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20658_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000010069","volume":"47","author":"T Gredmark","year":"1999","unstructured":"Gredmark, T., Bergman, B. & Hellstrom, L. Total fibronectin in maternal plasma as a predictor for preeclampsia. Gynecol. Obstet. Invest. 47, 89\u201394. https:\/\/doi.org\/10.1159\/000010069 (1999).","journal-title":"Gynecol. Obstet. Invest."},{"key":"20658_CR21","doi-asserted-by":"publisher","first-page":"20073","DOI":"10.1038\/srep20073","volume":"6","author":"NE Poveda","year":"2016","unstructured":"Poveda, N. E. et al. Serum adipsin levels throughout normal pregnancy and preeclampsia. Sci. Rep. 6, 20073. https:\/\/doi.org\/10.1038\/srep20073 (2016).","journal-title":"Sci. Rep."},{"key":"20658_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.113.02688","volume":"64","author":"T Wang","year":"2014","unstructured":"Wang, T. et al. Elevation of urinary adipsin in preeclampsia: Correlation with urine protein concentration and the potential use for a rapid diagnostic test. Hypertension 64, 846\u2013851. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02688 (2014).","journal-title":"Hypertension"},{"key":"20658_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/0002-9378(91)90706-w","volume":"164","author":"F Espana","year":"1991","unstructured":"Espana, F. et al. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia. Am. J. Obstet. Gynecol. 164, 1310\u20131316. https:\/\/doi.org\/10.1016\/0002-9378(91)90706-w (1991).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20658_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1071\/RD12384","volume":"26","author":"K Macintire","year":"2014","unstructured":"Macintire, K. et al. PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia. Reprod. Fertil. Dev. 26, 351\u2013357. https:\/\/doi.org\/10.1071\/RD12384 (2014).","journal-title":"Reprod. Fertil. Dev."},{"key":"20658_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s43032-019-00050-3","volume":"27","author":"LM Lamale-Smith","year":"2020","unstructured":"Lamale-Smith, L. M. et al. Uteroplacental ischemia is associated with increased PAPP-A2. Reprod. Sci. 27, 529\u2013536. https:\/\/doi.org\/10.1007\/s43032-019-00050-3 (2020).","journal-title":"Reprod. Sci."},{"key":"20658_CR26","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1210\/jcem.84.11.6120","volume":"84","author":"SW Kauma","year":"1999","unstructured":"Kauma, S. W., Bae-Jump, V. & Walsh, S. W. Hepatocyte growth factor stimulates trophoblast invasion: A potential mechanism for abnormal placentation in preeclampsia. J. Clin. Endocrinol. Metab. 84, 4092\u20134096. https:\/\/doi.org\/10.1210\/jcem.84.11.6120 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"20658_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejogrb.2019.05.036","volume":"240","author":"K Kupsamy","year":"2019","unstructured":"Kupsamy, K., Moodley, J. & Naicker, T. Hepatocyte growth factor and epidermal growth factor in HIV infected women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 240, 9\u201314. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.05.036 (2019).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"20658_CR28","doi-asserted-by":"publisher","first-page":"e65571","DOI":"10.1371\/journal.pone.0065571","volume":"8","author":"Q Wen","year":"2013","unstructured":"Wen, Q. et al. Peptidomic Identification of serum peptides diagnosing preeclampsia. PLoS ONE 8, e65571. https:\/\/doi.org\/10.1371\/journal.pone.0065571 (2013).","journal-title":"PLoS ONE"},{"key":"20658_CR29","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-14-0215","volume":"54","author":"LA Bach","year":"2015","unstructured":"Bach, L. A. Endothelial cells and the IGF system. J. Mol. Endocrinol. 54, R1-13. https:\/\/doi.org\/10.1530\/JME-14-0215 (2015).","journal-title":"J. Mol. Endocrinol."},{"key":"20658_CR30","doi-asserted-by":"publisher","first-page":"e12390","DOI":"10.1111\/cpr.12390","volume":"50","author":"S Lin","year":"2017","unstructured":"Lin, S. et al. IGF-1 promotes angiogenesis in endothelial cells\/adipose-derived stem cells co-culture system with activation of PI3K\/Akt signal pathway. Cell Prolif. 50, e12390. https:\/\/doi.org\/10.1111\/cpr.12390 (2017).","journal-title":"Cell Prolif."},{"key":"20658_CR31","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"20658_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211 (2009).","journal-title":"Nat. Protoc."},{"key":"20658_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313. https:\/\/doi.org\/10.1093\/nar\/gkn923 (2009).","journal-title":"Nucleic Acids Res."},{"key":"20658_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps, E. A., Thadhani, R., Benzing, T. & Karumanchi, S. A. Pre-eclampsia: Pathogenesis, novel diagnostics and therapies. Nat. Rev. Nephrol. 15, 275\u2013289. https:\/\/doi.org\/10.1038\/s41581-019-0119-6 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"20658_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","volume":"67","author":"SA Karumanchi","year":"2016","unstructured":"Karumanchi, S. A. Angiogenic factors in preeclampsia: From diagnosis to therapy. Hypertension 67, 1072\u20131079. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.06421 (2016).","journal-title":"Hypertension"},{"key":"20658_CR36","doi-asserted-by":"publisher","first-page":"e0217273","DOI":"10.1371\/journal.pone.0217273","volume":"14","author":"AL Tarca","year":"2019","unstructured":"Tarca, A. L. et al. The prediction of early preeclampsia: Results from a longitudinal proteomics study. PLoS ONE 14, e0217273. https:\/\/doi.org\/10.1371\/journal.pone.0217273 (2019).","journal-title":"PLoS ONE"},{"key":"20658_CR37","doi-asserted-by":"publisher","first-page":"e0181468","DOI":"10.1371\/journal.pone.0181468","volume":"12","author":"O Erez","year":"2017","unstructured":"Erez, O. et al. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLoS ONE 12, e0181468. https:\/\/doi.org\/10.1371\/journal.pone.0181468 (2017).","journal-title":"PLoS ONE"},{"key":"20658_CR38","doi-asserted-by":"publisher","first-page":"e10427","DOI":"10.15252\/emmm.201910427","volume":"11","author":"PE Geyer","year":"2019","unstructured":"Geyer, P. E. et al. Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies. EMBO Mol. Med. 11, e10427. https:\/\/doi.org\/10.15252\/emmm.201910427 (2019).","journal-title":"EMBO Mol. Med."},{"key":"20658_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672\u2013683. https:\/\/doi.org\/10.1056\/NEJMoa031884 (2004).","journal-title":"N. Engl. J. Med."},{"key":"20658_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1515\/jpm-2012-0248","volume":"41","author":"W Schaarschmidt","year":"2013","unstructured":"Schaarschmidt, W., Rana, S. & Stepan, H. The course of angiogenic factors in early- versus late-onset preeclampsia and HELLP syndrome. J. Perinat. Med. 41, 511\u2013516. https:\/\/doi.org\/10.1515\/jpm-2012-0248 (2013).","journal-title":"J. Perinat. Med."},{"key":"20658_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/clinem\/dgaa403","volume":"106","author":"N Todd","year":"2021","unstructured":"Todd, N. et al. Role of a novel angiogenesis FKBPL-CD44 pathway in preeclampsia risk stratification and mesenchymal stem cell treatment. J. Clin. Endocrinol. Metab. 106, 26\u201341. https:\/\/doi.org\/10.1210\/clinem\/dgaa403 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"20658_CR42","doi-asserted-by":"publisher","first-page":"21849","DOI":"10.1074\/jbc.M102191200","volume":"276","author":"MT Overgaard","year":"2001","unstructured":"Overgaard, M. T. et al. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J. Biol. Chem. 276, 21849\u201321853. https:\/\/doi.org\/10.1074\/jbc.M102191200 (2001).","journal-title":"J. Biol. Chem."},{"issue":"Suppl 2","key":"20658_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/humrep\/14.suppl_2.90","volume":"14","author":"JC Irwin","year":"1999","unstructured":"Irwin, J. C., Suen, L. F., Martina, N. A., Mark, S. P. & Giudice, L. C. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum. Reprod. 14(Suppl 2), 90\u201396. https:\/\/doi.org\/10.1093\/humrep\/14.suppl_2.90 (1999).","journal-title":"Hum. Reprod."},{"key":"20658_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.placenta.2009.01.012","volume":"30","author":"V Sitras","year":"2009","unstructured":"Sitras, V. et al. Differential placental gene expression in severe preeclampsia. Placenta 30, 424\u2013433. https:\/\/doi.org\/10.1016\/j.placenta.2009.01.012 (2009).","journal-title":"Placenta"},{"key":"20658_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1210\/en.2008-0990","volume":"150","author":"VD Winn","year":"2009","unstructured":"Winn, V. D. et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 150, 452\u2013462. https:\/\/doi.org\/10.1210\/en.2008-0990 (2009).","journal-title":"Endocrinology"},{"key":"20658_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/molehr\/gan054","volume":"14","author":"H Nishizawa","year":"2008","unstructured":"Nishizawa, H. et al. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol. Hum. Reprod. 14, 595\u2013602. https:\/\/doi.org\/10.1093\/molehr\/gan054 (2008).","journal-title":"Mol. Hum. Reprod."},{"key":"20658_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","volume":"816","author":"B Emini Veseli","year":"2017","unstructured":"Emini Veseli, B. et al. Animal models of atherosclerosis. Eur. J. Pharmacol. 816, 3\u201313. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.010 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"20658_CR48","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1210\/en.2007-0571","volume":"148","author":"TC Nichols","year":"2007","unstructured":"Nichols, T. C. et al. Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia. Endocrinology 148, 5002\u20135010. https:\/\/doi.org\/10.1210\/en.2007-0571 (2007).","journal-title":"Endocrinology"},{"key":"20658_CR49","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1210\/en.2006-0493","volume":"147","author":"ZT Resch","year":"2006","unstructured":"Resch, Z. T., Simari, R. D. & Conover, C. A. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 147, 5634\u20135640. https:\/\/doi.org\/10.1210\/en.2006-0493 (2006).","journal-title":"Endocrinology"},{"key":"20658_CR50","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/CIRCRESAHA.106.146183","volume":"100","author":"SC Harrington","year":"2007","unstructured":"Harrington, S. C., Simari, R. D. & Conover, C. A. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ. Res. 100, 1696\u20131702. https:\/\/doi.org\/10.1161\/CIRCRESAHA.106.146183 (2007).","journal-title":"Circ. Res."},{"key":"20658_CR51","doi-asserted-by":"publisher","first-page":"H284","DOI":"10.1152\/ajpheart.00904.2009","volume":"299","author":"CA Conover","year":"2010","unstructured":"Conover, C. A. et al. Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am. J. Physiol. Heart Circ. Physiol. 299, H284-291. https:\/\/doi.org\/10.1152\/ajpheart.00904.2009 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"20658_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12265-015-9666-9","volume":"9","author":"CA Conover","year":"2016","unstructured":"Conover, C. A., Bale, L. K. & Oxvig, C. Targeted inhibition of pregnancy-associated plasma protein-A activity reduces atherosclerotic plaque burden in mice. J. Cardiovasc. Transl. Res. 9, 77\u201379. https:\/\/doi.org\/10.1007\/s12265-015-9666-9 (2016).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"20658_CR53","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.110.157743","volume":"56","author":"AC Staff","year":"2010","unstructured":"Staff, A. C., Dechend, R. & Pijnenborg, R. Learning from the placenta: Acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 56, 1026\u20131034. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.157743 (2010).","journal-title":"Hypertension"},{"key":"20658_CR54","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","volume":"52","author":"H Valensise","year":"2008","unstructured":"Valensise, H., Vasapollo, B., Gagliardi, G. & Novelli, G. P. Early and late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52, 873\u2013880. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.117358 (2008).","journal-title":"Hypertension"},{"key":"20658_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon, A. C. et al. The role of inflammation in the pathology of preeclampsia. Clin. Sci. (Lond) 130, 409\u2013419. https:\/\/doi.org\/10.1042\/CS20150702 (2016).","journal-title":"Clin. Sci. (Lond)"},{"key":"20658_CR56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0270-9295(04)00127-5","volume":"24","author":"CW Redman","year":"2004","unstructured":"Redman, C. W. & Sargent, I. L. Preeclampsia and the systemic inflammatory response. Semin. Nephrol. 24, 565\u2013570. https:\/\/doi.org\/10.1016\/s0270-9295(04)00127-5 (2004).","journal-title":"Semin. Nephrol."},{"key":"20658_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tjog.2014.03.006","volume":"54","author":"D Mihu","year":"2015","unstructured":"Mihu, D., Razvan, C., Malutan, A. & Mihaela, C. Evaluation of maternal systemic inflammatory response in preeclampsia. Taiwan. J. Obstet. Gynecol. 54, 160\u2013166. https:\/\/doi.org\/10.1016\/j.tjog.2014.03.006 (2015).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"20658_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/org.4.4.6926","volume":"4","author":"EL Pardue","year":"2008","unstructured":"Pardue, E. L., Ibrahim, S. & Ramamurthi, A. Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 4, 203\u2013214. https:\/\/doi.org\/10.4161\/org.4.4.6926 (2008).","journal-title":"Organogenesis"},{"key":"20658_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.matbio.2006.08.261","volume":"26","author":"M Slevin","year":"2007","unstructured":"Slevin, M. et al. Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26, 58\u201368. https:\/\/doi.org\/10.1016\/j.matbio.2006.08.261 (2007).","journal-title":"Matrix Biol."},{"key":"20658_CR60","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1021\/acs.jproteome.9b00090","volume":"18","author":"DJ Harney","year":"2019","unstructured":"Harney, D. J. et al. Proteomic analysis of human plasma during Intermittent fasting. J. Proteome Res. 18, 2228\u20132240. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00090 (2019).","journal-title":"J. Proteome Res."},{"key":"20658_CR61","doi-asserted-by":"publisher","first-page":"103998","DOI":"10.1016\/j.jprot.2020.103998","volume":"231","author":"MB O'Rourke","year":"2021","unstructured":"O\u2019Rourke, M. B., Sahni, S., Samra, J., Mittal, A. & Molloy, M. P. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. J. Proteomics 231, 103998. https:\/\/doi.org\/10.1016\/j.jprot.2020.103998 (2021).","journal-title":"J. Proteomics"},{"key":"20658_CR62","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.08.013","volume":"175","author":"B Roediger","year":"2018","unstructured":"Roediger, B. et al. An atypical parvovirus drives chronic tubulointerstitial nephropathy and kidney fibrosis. Cell 175, 530-543 e524. https:\/\/doi.org\/10.1016\/j.cell.2018.08.013 (2018).","journal-title":"Cell"},{"key":"20658_CR63","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"20658_CR64","doi-asserted-by":"publisher","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","volume":"39","author":"D Croft","year":"2011","unstructured":"Croft, D. et al. Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691-697. https:\/\/doi.org\/10.1093\/nar\/gkq1018 (2011).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20658-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20658-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20658-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:08:29Z","timestamp":1667992109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20658-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20658"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20658-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19099"}}